Systematic Reviews

The EBM Evidence Hierarchy: Which Medical Studies Can You Actually Trust? Evidence-based Medicine (EBM) requires medical research to underpin clinical practice and policy. A survival guide is needed for decoding medical research. There is a need for a rule-of-thumb to classify research as either evidentiary or non-evidentiary, i.e., an evidence ladder. This is based on study design and ranks the most valid or bias-free designs highest. Randomized trials rank higher than cohort studies, which in turn rank higher than case-control studies. Case reports, expert opinions and consensus are not considered evidentiary. This vlog explains how precision is added to validity in refining the evidence hierarchy.

Medical Jargon BUSTED: The Ultimate Evidence-Based Medicine (EBM) Glossary. Ever wondered why research takes years to reach medical practice? There isn't a hidden path from medical research to patient care if you break it down into steps, bridging the research-practice gap. You can then begin to understand why medical research often goes unused, and it is difficult to transform research into better patient care. Feeling lost in a sea of complex medical terms whenever you try to understand health research or your doctor's advice? This video breaks down the essential vocabulary of evidence-based medicine, empowering you with the clarity as to what it means for informed health decisions. Alternative terms such as knowledge transfer of KT, EBP, EBHC, Research translation, etc. are compared and contrasted. Glossary of Terms for Healthcare Research is a project based on terms defined in Professor Khalid Khan's books. 3rd Edition of Professor Khalid Khan's award-winning ...

Science-based Fitness and Nutrition has been blown but 100s of retracted articles. Sports Science and weight loss research misconduct and fraud are prevalent in top institutions and journals. Where can the public, trainers and nutritionists turn to?

Evidence synthesis of randomised clinical trials (2 of 2): This is the 2nd part of a two-part lecture delivered on ”Systematic Review Of Randomized Controlled Trials” in the OIC University of Uganda on 21 March 2023 by Professor Khalid Khan, COMSTECH Distinguished Scholar, and Beatriz Galindo Distinguished Investigator, Faculty of Medicine, University of Granada, Spain.

Evidence synthesis of randomised clinical trials (1 of 2): This is the 1st part of a two-part lecture delivered on ”Systematic Review Of Randomized Controlled Trials” in the OIC University of Uganda on 21 March 2023 by Professor Khalid Khan, COMSTECH Distinguished Scholar, and Beatriz Galindo Distinguished Investigator, Faculty of Medicine, University of Granada, Spain.

Elder abuse, a critical human rights concern and public health issue, has been extensively studied in recent years. Various reviews have consolidated primary research to assess its prevalence. This vlog presents an umbrella review highlighting the significantly high estimated global prevalence rate of elder abuse in both community and care settings. Despite challenges like evidence quality and variability, it is undeniable that elder abuse is pervasive with a broad impact. The emphasis should now turn towards implementing interventions and policies to combat this type of abuse.

The integrity of research, especially in clinical trials, is crucial for the development of medications and treatments. Behind each breakthrough lie the contributions of countless patients who selflessly participate in these trials. Despite the current emphasis on COVID-19, there have been instances of research articles being retracted. While some retractions stem from unintentional errors or technical flaws rather than deliberate deceit, maintaining honesty throughout the research process is paramount. It is essential to recognize that the value of clinical trials heavily depends on the integrity of the data they generate. Surprisingly, many medical training programs do not adequately address the importance of clinical trial integrity. Moreover, numerous countries face challenges due to insufficient medical infrastructure and expertise in conducting trials. To enhance the credibility of clinical trials, transparency must be upheld at every research phase, starting from pre-registratio...